more_reports

The Latest Regenerative Medicine Articles from Streetwise Reports

Biotech Enters Agreement with Co. Behind Tegoprubart

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) likely will use this new monoclonal antibody as an immunosuppressant in its Phase 1/2 trial's Cohort C instead of previously used tacrolimus, noted an H.C. Wainwright & Co. report.
Tags: Regenerative MedicineMedical Devices

One Co. With Cell Holding Device Stands Out in T1D Space

Research Report
  ()
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) alone has shown favorable outcomes in a trial when patients with this disease were treated with an implanted device containing donor islets, noted an H.C. Wainwright & Co. report.
Tags: Medical DevicesRegenerative Medicine

Cell Pouch Co. Peer Aborts Program Using Like Device

Research Report
  ()
The implications for Cell Pouch, an implantable cell delivery vehicle, and the biotech behind it are positive, noted a Leede Financial Inc. report.
Tags: Medical DevicesRegenerative Medicine

Showing Results: 1 to 3 of 3